Caris Life Sciences Inc
(CAI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,134 | 52,553 | 53,821 | 45,741 | 17,671 |
| Receivables | 63,745 | 55,284 | 58,022 | 51,872 | 51,758 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 2,189 |
| Other current assets | 19,959 | 21,158 | 18,150 | 18,551 | 11,544 |
| TOTAL | $135,153 | $131,150 | $144,799 | $130,967 | $95,114 |
| Non-Current Assets | |||||
| PPE Net | 1,807,560 | 1,748,885 | 1,565,722 | 1,466,482 | 1,212,081 |
| Investments And Advances | 80,582 | 82,210 | 76,814 | 68,210 | 74,929 |
| Intangibles | 25,485 | 4,128 | 273 | 677 | 1,441 |
| Other Non-Current Assets | 7,154 | 7,212 | 8,232 | 9,253 | 4,376 |
| TOTAL | $1,920,781 | $1,842,435 | $1,651,041 | $1,544,622 | $1,292,827 |
| Total Assets | $2,055,934 | $1,973,585 | $1,795,840 | $1,675,589 | $1,387,941 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 95,527 | 169,249 | 203,199 | 74,080 | 61,044 |
| Accounts payable and accrued liabilities | 46,088 | 28,664 | 28,779 | 67,998 | 27,135 |
| Accrued Expenses | 11,778 | 4,813 | 9,029 | 6,230 | 8,465 |
| TOTAL | $164,006 | $214,716 | $249,194 | $157,091 | $106,779 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,380,499 | 1,250,560 | 1,058,754 | 1,058,628 | 888,990 |
| Deferred Revenues | 10,613 | 11,990 | 7,172 | 6,862 | 7,893 |
| Other Non-Current Liabilities | 2,084 | -134 | -111 | -594 | -816 |
| TOTAL | $1,434,424 | $1,298,764 | $1,103,741 | $1,103,372 | $934,317 |
| Total Liabilities | $1,598,430 | $1,513,480 | $1,352,935 | $1,260,463 | $1,041,096 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,057 | 19,922 | 20,788 | 22,241 | 22,055 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 324,576 | 318,579 | 292,897 | 232,623 | 168,697 |
| Other shareholders' equity | -8,132 | -6,999 | -4,888 | -1,762 | -2,917 |
| TOTAL | $457,504 | $460,105 | $442,905 | $415,126 | $346,845 |
| Total Liabilities And Equity | $2,055,934 | $1,973,585 | $1,795,840 | $1,675,589 | $1,387,941 |